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Physiology (chapter 2). In chapter 2 it is emphasized that penile erections result from complex 
interactions between vascular, neural, hormonal and psychological factors and that they arise 
within diff erent contexts, including the so-called “sleep-related erections” (SREs). SREs are initiated 
very shortly after the onset of Rapid Eye Movement (REM) sleep periods and represent an intrinsic 
mechanism protecting the morphodynamic integrity of the corpora cavernosa (CC). Obviously, 
intact connections between brain, spine and penis are required to generate SREs. Diff erent from 
erotic erections, the lateral preoptic area (LPOA) in the cerebral cortex plays an essential role in the 
generation of SREs by projecting on the spinal cord via the paraventricular nucleus (PVN) and the 
paragigantocellular nucleus (nGPi). Gamma aminobutyric acid (GABA), glutamate and, to a lesser 
extent, dopamine are the main neurotransmitters involved in the regulation of SREs. Moreover, 
a remarkable diff erence between the physiology of erotically generated penile erections and 
those during sleep is the role of the striated pelviperineal muscles. Karacan observed increased 
activity of these muscles during REM sleep and related erection. (1) The authors suggested that 
the bulbospongious (BS) and ischiocavernous (IC) muscles might have a role in human penile 
erection, since they saw bursts of phasic musculovascular activity being more frequently present 
during ascending and maximal tumescence than during detumescence and baseline. However, 
a later study showed that such a role was not reserved for the pelviperineal striated muscles 
during erotic erections. Despite the fact that a man can voluntary contract them during erection 
to gain maximum rigidity and increased circumference of the penis, no involuntary contractions 
or bursts of these muscles were required to initiate or maintain erotic erection. (2)
Pathology (chapters 3-5). The existence of SREs is normally a favourable sign, indicating that the 
organic conditions needed for erotic erectile functioning are suffi  ciently available. However, in 
some males SREs cause major misery. These so called “sleep-related painful erections” (SRPEs) are 
discussed in chapter 3 and described as nocturnal episodes with rigid penile erection accompanied 
by an unpleasant oppressive, sometimes burning sensation or even excruciating pain inside the 
penis that awakens the male concerned. Fragmented REM sleep and frequent awakenings result 
in severe sleep deprivation, which is the reason that this condition is considered a parasomnia. A 
parasomnia is defi ned as undesirable physical phenomena, events (movements, behaviours) or 
experiences (emotions, perceptions, dreams) that occur during falling asleep, sleep or awakening. 
A well-known other example is sleepwalking.
Despite of the erotic erections being normal, some patients’ marital life is severely disturbed due 
to stress and anxiety symptoms, in most patients secondarely to the sleep defi cit. In our study 
(chapter 5) all patients complained about sleep deprivation and nearly 80% suff ered from daytime 
sleepiness and fatigue. In 25% this had forced them to partial or complete work absenteeism. The 
SRPEs occurred every night in all these patients, with a median frequency of three times per night.
Summary
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SRPEs have to be distinguished from intermittent priapism, because the erections are of much 
shorter duration (mostly <15 minutes) and there is always recovery without the need for 
intervention other than cooling, micturition or walking around. Moreover, SRPEs are not related 
to haematological diseases or any other medical comorbidities.
As in other studies the results of nocturnal penile tumescence and rigidity (NPT-R) measurements, 
that we performed to visualize and objectify the nocturnal erection pattern, were inconsistent 
(chapter 4). In the existing literature, we found 26 NPT-R observations of which the results 
varied from short, partial, and/or incomplete erections (n=3), to prolonged, more frequent 
periods of nocturnal erection with increased rigidity and prolonged total tumescence time 
(n=14), and completely normal results (n=9). Because of this wide variety, NPT-R measurement 
is not appropriate to diagnose the extent and seriousness of the SRPE symptoms. However, this 
diagnostic method might well be used to monitor disease progression and/or evaluate treatment 
efficacy when the pre-treatment NPT-R measurement showed an abnormal pattern. The same 
applies to the role of polysomnography in diagnosing SRPEs and the evaluation of treatment 
response.
Based on the observations described in chapters 4 and 5, we hypothesize that hypertonia/
hypertrophy of the pelvic floor muscles is the most plausible explanation for SRPEs. An 
increased and prolonged tone of the IC and BS muscles can contribute to the development of 
a penile compartment syndrome and prevention of detumescence after erection. Moreover, the 
hypertonia itself may be an explanation for the pain experienced during SRPEs. It elucidates the 
radiating character of the pain to adjacent areas (groin, lower abdomen, scrotum, perineum) 
and the relatively high concomitant occurrence of lower urinary tract symptoms reported in 
our study population. This hypothesis is supported by the above-mentioned observation of 
increased (pelvic) striated muscle activity during REM-sleep, but the absence of (involuntary) BS 
and IC muscle involvement during erotic penile erections. This corresponds to the fact that erotic 
erections are undisturbed in SRPE patients. However, this can only be stated as an assumption 
rather than a scientifically substantiated explanation since there are only limited studies available 
on this subject. It would be interesting to elucidate the role of the pelvic floor muscles during 
erotic- vs. sleep-related erections by using electromygraphic studies of the striated pelvic muscles 
in homogenous groups.
With regard to the treatment of SRPE, baclofen in a starting dose of 10mg at bedtime appeared to 
be the most effective (chapter 5). We hypothesize that the efficacy of baclofen in SRPEs is based 
on muscle relaxation of the ischiocavernous, bulbospongious and other pelvic floor muscles, 
since it is a potent GABA-ß receptor agonist, that inhibits the release of glutamate and aspartate. 
92,8% of the patients experienced partial or complete remission of symptoms on the short term. 
Unfortunately, most patients experienced full relapse of symptoms after discontinuation of 
baclofen. Long term use of baclofen was only applied in 3 of the 14 patients, so the feasibility and 
safety of long term use deserves further assessment.
Chapter 11
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Conclusions. Scientifi c research on the pathophysiology and treatment of SRPE is still very limited. 
It is a poorly recognized condition. The patients who overcome their embarrassment and dare 
to consult a physician are often left disappointed due to the lack of knowledge about the 
existence of this condition. For that reason, the main goal of our clinical studies and meta-analysis 
concerning the pathophysiology and treatments of SRPEs was to gain more awareness and 
recognition of this phenomenon among physicians, by providing an unambiguous description 
of the symptomatology and diagnostic features. We came one small step closer towards an 
evidence-based advice on how diagnostics and treatments should be used and interpreted.
In the fi rst three months after publication of the articles from chapters 4 and 5, there were already 
3 new SRPE patients referred to our outpatient clinic, whereas it took 20 years to collect 24 patients 
for this study. This is an indication that the occurrence of SRPE is in fact not as rare as one thinks 
it is. We hope that our fi rst steps will contribute to more awareness about SRPEs. This may lead 
to prospective randomized trials in the near future. In our view, especially the role of the pelvic 
fl oor muscles during SR(P)E and the feasibility of long-term baclofen use needs further attention.
Priapism
Past (chapter 6). Chapter 6 contains a comprehensive overview from original primary sources 
concerning the developments in the pathophysiological understanding and treatment of 
priapism throughout the ages. Painful and prolonged erections have fascinated mankind for 
centuries. The phenomenon was named after Priapus, the god of fertility who was depicted with 
an enormous phallus. The fi rst recorded evidence of priapism was found in the Egyptian Ebers 
papyrus originating from 1550 BC. In 1552 AD, the French physician Thierry de Héry was the fi rst 
to describe priapism in modern scientifi c literature, with clear references to Galen. Until the 19th 
century, treatments were without real effi  cacy, except sometimes a temporary analgesic eff ect. 
The list of used ‘medications’ is long, varying from rhubarb, chamomile, fl owers of the elderberry 
and opium. In the 19th century the treatment strategies were threefold; localized medical and 
surgical therapies, systemic treatments such as emetics and bloodletting and those specifi cally 
intended to sedate or temper sexual desire. In 1824 Thomas Callaway was the fi rst to perform 
surgical treatment. However, without antibiotics the infection rate was high and the results with 
regard of erectile function were disappointing. Less invasive treatments became more popular 
e.g. the technique that was suggested by McKay and Colston, who performed aspiration of clots 
and washing the CC with saline. In 1984 Brindley reported his fi rst successful experiment with 
the intracavernous injection of the adrenergic drug metaraminol and 20 years earlier the fi rst 
“shunting-technique” was introduced by Grayhack to increase and create a continuous drainage 
from the CC. After Grayhack, Quackles/Bolliger, Sacher, Al-Ghorab, Winter and Ebbehøj introduced 
several techniques to create a proximal or distal shunt between the CC and the spongious body 
around the urethra. After its introduction in 2008, the T-shunt with ‘snake tunnelling’ became 
more or less the procedure of fi rst choice after failed intracavernous treatment.  
Summary
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High-flow priapism, the non-ischemic form, was first described as a different form of priapism in 
1938 in France.
Present (chapters 7 and 8): Priapism is rare and unique condition that acquires scientific attention 
for many reasons. We differentiate three forms: ischemic, non-ischemic and intermittent priapism, 
of which the first has the most potential to result in irreversible erectile dysfunction (ED). Ischemic 
priapism is also the most common form and needs urgent intervention. Currently, treatment 
advice is still based on relatively small uncontrolled case- series and expert opinions. The aetiology 
of priapism varies widely and can be caused by for example spinal cord lesions, cerebrovascular 
incidents, brain tumours, use of (psychiatric) medication, spinal anaesthesia, intoxications, 
perineal trauma, haematological disease etcetera. As a result of this, not only urologists or general 
practitioners, but many different specialists such as neurologists, psychiatrists, internal doctors, 
critical care unit doctors, paediatricians, cardiologists and doctors working on the emergency 
department may have to deal with this condition. Unfortunately, in daily practice experts 
experience that these (non-urologic) specialists and other executive personnel working on their 
departments either have troubles recognizing the (seriousness of the) condition or don’t know 
how to handle once they do. As a result, treatment is performed unnecessarily late with a negative 
influence on its outcome.
Chapter 7 describes the 85 different priapism patients registered in the past 32 years in our hospital. 
They experienced episodes of priapism all together. 77,6% suffered from the ischemic form and 
all were treated according to the European guidelines. The duration of priapism appeared to be 
the most important predictor of treatment success. Another remarkable observation was the 
increasing recreational use of illegally obtained and intracavernous injected pro-erectile drugs 
(e.g. Androskat®) in patients with a normal erectile function. Homosexually oriented men or those 
participating in swinger communities were more frequently involved. In our experience they 
formed a poorly informed group, struggling even more with feelings of guilt and shame than the 
non-recreational users. As a result, patient delay was significantly longer and treatments hardly 
successful.
In our study population aspiration and irrigation did not lead to permanent detumescence if the 
priapism lasted >36 hours. Neither could shunt surgery. In this situation one may consider the 
early implantation of an erection prosthesis.
A less common, but also potentially dangerous form includes intermittent priapism. It is 
defined as frequently recurring episodes of ischemic priapism and is most likely due to aberrant 
nitric oxide (NO) signalling, caused by endothelial damage and haemolysis. The decreased 
availability of NO in the CC results in a compensatory deregulation of phosphodiesterase type 
5 (PDE5), causing accumulation of cyclic guanosine monophosphate (cGMP) and consequently 
uncontrolled vasodilatation. Patients suffering from haematological dyscrasias, such as sickle cell 
disease, are frequently affected. Most often, these episodes are self-limiting and occur during the 
Chapter 11
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night, triggered/initiated by sleep- related erections. However, about one third of the patients 
with intermittent priapism experience progression to a persistent ischemic form that requires 
intervention. For this reason, treatment should be focussed on the prevention of future episodes, 
for which anti- androgens, agonists of gonadotropin releasing hormones and PDE-5 inhibitors are 
considered to be appropriate.
A more benign form includes non-ischemic- or “high-fl ow” priapism. The aetiology is roughly 
divided into traumatic (causing an arterial-cavernous fi stula) or neurological, where an impaired 
neurological control results in incessant infl ux of blood to the CC when sympathetic infl uences 
originating from Th11-12 in the spinal cord are cut off . For this partly rigid, non- painful erection a 
conservative treatment approach is justifi ed and the priapism will resolve spontaneously in most 
cases. However, as described in chapter 8, arterial-cavernosal fi stulae may persist and a pseudo-
aneurysm can occur. For these patients, selective embolization to achieve closure of the fi stula is 
the most safe and eff ective treatment. The right timing of such a procedure is, however, not yet 
known.
In chapter 9, we focused on the metabolic derangements that take place in the CC during 
ischemic priapism. A colleague from the critical care department found extremely aberrant 
blood gas results in many of the samples obtained from urological patients at the Emergency 
Department. In his view these could not be compatible with life. It seemed as though an absolute 
metabolic endpoint was reached. However, he did not know that these samples were aspirated 
from the CC of patients with ischemic priapism. This serendipitous study was innovative in many 
ways, since in vivo studies concerning metabolic changes and acid base disorders are usually 
performed in complex open systems. Metabolic examination of blood aspirates from the CC 
during episodes of ischemic priapism, however, allows the recognition of a unique metabolic 
state in a closed compartment. We found a very characteristic combination of extreme hypoxia, 
hypercapnia, glycopenia and hyperlactatemia in the cavernous blood during ischemic priapism. 
The analyses refl ected an extreme respiratory acidosis combined with a metabolic acidosis, 
indicating the exhaustion of all substrates needed for adenosine triphosphate (ATP) production. 
The acidity of some samples was noteworthy as it approached levels that are considered to be 
the lowest compatible with life (pH value of 6.6). Moreover, we observed mean intracavernous 
glucose levels to be as low as 1.1 mmol/l. Systemically, severe (respiratory) lactate acidosis is 
accompanied by elevated glucose levels produced from hepatic glycogen storages. Obviously, 
no such compensatory mechanism is available in the CC. So, this results in frequently decreased 
or even absent glucose levels in the cavernous blood, exposing the erectile tissue to a complete 
exhaustion of fuel reserves. We think that this ATP-defi cient state may render the administration of 
phenylephrine ineff ective since it will eventually lead to cell apoptosis. In this context we suggest 
to dilute phenylephrine in 1 ml of dextrose (i.e. glucose) 5% instead of NaCl 0.9% to increase its 
eff ectivity by recovering from the glycopenic state and interrupt cell apoptosis. In our opinion, it 
deserves further prospective and controlled clinical studies to test our hypothesis.
Summary
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Future (chapter 10): After reading the aforementioned chapters on priapism, one can conclude 
that there is still much to be yielded in this field. Especially, ischemic priapism lasting > 36 hours 
remains a therapeutic challenge. According to the recent guidelines these patients are candidates 
for early prosthesis implantation. Unfortunately, early prosthesis surgery is risky and sometimes 
difficult, with high complication and revision rates. Moreover, possible vital cavernous tissue, will 
be destroyed by prosthesis implantation. For that reason, it is advisable to perform an MRI of the 
penis to assess the extensiveness of intracavernous necrosis.
In chapter 10 we revive and upgrade the idea of an ancient surgical approach that was first 
performed by Thomas Callaway in 1824 in a male with long lasting priapism. On a Thiel’s cadaver, 
we performed a full-length incision of the CC, extending from the coronal ridge, up to the crurae 
in the perineum.
We think that with this method the high intracavernous pressure will cease to exist and not get 
the chance to rebuild, since the incision site will be left open for the first 24-48 hours. In such 
a way there will be time for venous drainage to recover and vital tissue in the CC will again be 
provided with oxygenated blood. In fact, it is not more than a so called “fasciotomy” that is also 
performed in patients with compartment syndromes elsewhere in the body. Where infection, 
due to lack of antibiotics, was a major obstacle to perform a fasciotomy in the time of Thomas 
Callaway, we believe that it is a promising intervention to prevent ED in patients with refractory 
priapism in the next future.
Chapter 11
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